SCHEMBL6908438

SCHEMBL6908438

CC(=O)c1cc(OC2CCCCO2)ccc1OC1CCCCO1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PDE4B Q07343 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD11B1 P28845 1/20 0.40
CREBBP Q92793 1/20 0.39
PTPN1 P18031 3/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
DHFR P00374 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119366 0.87 MAOB (0.40) MEN1KMT2AHSD11B1CREBBPPTPN1
SCHEMBL4125320 0.85 PTPN1 (0.41) GAANPSR1PDE4BMEN1KMT2A
SCHEMBL2968461 0.84 ALDH1A1 (0.50) CYP3A4MAPK1
SCHEMBL5618972 0.84 MEN1 (0.43) PDE4BMEN1KMT2AHSD11B1CREBBP
SCHEMBL30065877 0.84 ALDH1A1 (0.50) CYP3A4MAPK1
SCHEMBL3685410 0.83 MAOB (0.43) MEN1KMT2AHSD11B1CTSDBACE1
SCHEMBL27445640 0.83 HSD11B1 (0.41) PDE4BMEN1KMT2AHSD11B1CREBBP
SCHEMBL8771671 0.81 KDM4E (0.45) NPSR1PDE4BMEN1KMT2APTPN1
SCHEMBL2281345 0.79 SMN1; SMN2 (0.60) GAAMEN1KMT2ACREBBPLMNA
SCHEMBL16991669 0.78 PDE4B (0.42) PDE4BMEN1KMT2AHSD11B1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040176471-A1 Novel chalcone derivatives and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176471-A1 Novel chalcone derivatives and pharmaceutical compositions comprising the same PTGS1, PTGES2, PTGES GAA 1215/4885NPSR1 2048/4885PDE4B 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.